APHA Webinar: Developing and Distributing a COVID Vaccine

June 10, 2020 | 2 – 3:30 p.m. AZ Time

This COVID-19 webinar will discuss the road to immunity during COVID-19, including the basics of vaccine development, how developing a vaccine for COVID-19 differs from “traditional” vaccine development, and what actions can be taken now and in the coming months to ensure that our supply chain is ready to manufacture millions of doses of a vaccine.

The webinar will begin with an introduction from the session’s moderator, Paul A. Offit, Director, Vaccine Education Center, Children’s Hospital of Philadelphia, and then feature a panel discussion among expert speakers, including:

  • John R. Mascola – Director, Dale and Betty Bumpers Vaccine Research Center, National Institute of Allergy and Infectious Diseases

  • Kathleen M. Neuzil – Myron M. Levine MD Professor in Vaccinology and Director, Center for Vaccine Development and Global Health, University of Maryland School of Medicine

  • Richard J. Hatchett – Chief Executive Officer, Coalition for Epidemic Preparedness Innovations (CEPI)

  • Seth Berkley – Chief Executive Officer, Gavi, The Vaccine Alliance

The panel discussion will be followed by a Q&A session with the webinar audience.

This webinar has also been approved for 1.5 continuing education credits for CPH, CME, CNE or CHES. Several days after attending the webinar, those who watched the entire activity will receive an email with info on how to complete the online evaluation and then claim their credits.

Register to attend the free webinar

Retail Marijuana Voter Initiative Likely to be on the Ballot

What does the public health evidence show & what position should we take?

This November there will likely be a Citizen’s Initiative on that ballot called Smart and Safe Arizona.  It would legalize the possession and use of up to 1 ounce of marijuana (for people 21 and over) and set up licensed retail stores where up to 1 ounce of Cannabis can be sold to adults 21 and over.  It would also offer expungement of some previous convictions for marijuana convictions. Here’s a link to the statutory language that is being circulated to get signatures. 

We have existing Resolution regarding the legalization and retail sale of marijuana (it’s posted on our members only website) but the Resolution doesn’t specifically address the Initiative that will likely be before Arizona voters this fall. 

To help inform our members and Board about what position to take on the Initiative, we engaged with a group if interns that have developed an analysis of the Initiative from a public health perspective. We asked the team to conduct:

A literature review and analysis of the public health impact that has occurred in other states that have legalized the retail sale of marijuana. For example, students may want to use Colorado’s report entitled Monitoring Health Concerns Related to Marijuana a resource for the analysis.

A literature review and an evaluation of the public health benefits from the criminal justice reform components including the expungement opportunities in the Initiative that can improve the social determinants of health.

An analysis of the public health benefits and improvements to the social determinants of health from the social investments that would result from the increased revenue from the sale of retail marijuana.

A comparison of the language in the Smart and Safe Arizona language to the recommendations in the American Public Health Association’s Policy Statement entitled Regulating Commercially Legalized Marijuana as a Public Health Priority and conduct a gap analysis to determine whether there are areas in the Initiative that do not meet the recommendations in the APHA Policy Statement.

We received the analysis from our first team of interns this week.  I won’t go into the details of what the team discovered (I’ll do that in a future policy update) but thought I’d pass the work along to you so you can start digging in. More details next week on what the report says.

A huge Thank You to our team of interns from A.T. Still University Apeldin Aghassi, Zola Bayarsaikhan, Erin Maruska, and Emily Winter for developing this very good report.

BTW: We don’t have much time to decide what position to take on the Initiative. Comments to the Voter Guide are due on Wednesday, June 17!

AzPHA Stands Against Racism

AzPHA Board of Director’s Statement

June 1, 2020

For decades, public health research has recognized racism and discrimination (or systemic violence) as fundamental causes of health disparities and inequities. It is time to move beyond silence, guilt, denial, and shock and accept our individual and collective roles in acting to demolish these centuries old systems of oppression.

As leaders in public health, we accept our responsibility in dismantling the systems of oppression that have long afforded many of us privilege and comfort. AzPHA is committed to working with our board and membership to integrate anti-racist education and actionable strategies for eliminating racism in order to realize health equity. In alignment with the W.K. Kellogg Foundation and APHA’s call for racial healing, we commit to intentionally engaging people from all racial and ethnic groups in order to build understanding, communication, compassion, and respect for one another.

Recognizing that complacency upholds the status quo, we have work to do. The drivers of structural inequality and race-based violence are not “out there,” or “with them,” they are baked into our own workplaces, associations, neighborhoods, families, and minds. And it’s our responsibility and our obligation as public servants to hold a light to injustice and to confront our biases.

As Arizona’s independent voice for public health, we commit to being accountable to our members and all Arizonans for confronting the myriad ways racism persists in public health and health care.

ASU Biodesign Develops Accurate Diagnostic Saliva-based COVID Test

One of the big challenges with the US’ COVID response has been the lack of testing capacity.  In part, those challenges hve been as a result of supply chain issues with the test kits- but also because the test is invasive and requires personal protective equipment. A new test that would be easy to use would make a real difference.  

For the past couple of weeks, ASU’s Biodesign Institute has been pilot testing the saliva-based test.  They have been using comparing results with their new self-administered saliva test to results using the classic nasal swab test.

So far, they’ve found that the saliva-based tests were just as good, if not even better, as those collected from nasal swab tests.

The saliva test is as simple as spitting into a screw-top tube through a straw, making testing way easier and also improving the supply of test kits and bringing the cost of testing. 

Judge Rules ADHS Can Withhold  Care Home Case Data

A couple of weeks ago several news outlets including The Arizona Republic sued the ADHS arguing that they have a duty to disclose the number of COVID-19 cases and the supply and use of PPE in Arizona nursing homes and assisted living centers. The plaintiffs  believe it’s of particular public interest because the majority of deaths in AZ have come from cases in these facilities.

The state has declined to disclose the information because they believe existing communicable disease confidentiality laws and language in ARS 36-783 (E) prevents them from disclosing the info. That exact language says:

… public health authorities shall maintain as confidential any information or a particular part of information provided under this section that, if made public, would divulge the trade secrets of a person or business or; other information likely to cause substantial harm to the person’s or business’ competitive position.

You can see the ADHS’ response to the suit here. Other arguments made by the agency include that disclosing the information will “Have deleterious effects in the community’s trust that the Department can prevent infectious disease.”

Friday the judge deferred to the Department and ruled that they can continue to not disclose which nursing homes and assisted living centers have cases and how many.  However, CMS has suggested that they will be releasing these data in the coming days

Biotech Company Says they had Encouraging Phase I Vaccine Safety Results (n=45)

Biotech company Moderna put out a press release this week saying that the initial Phase I results for a small study of 45 volunteers found that their experimental vaccine worked and had minor side effects. On the efficacy side of the table, they found that:

“…Dose dependent increases in immunogenicity were seen across the three dose levels, and between prime and boost within the 25 µg and 100 µg dose levels. All participants ages 18-55 (n=15 per cohort) across all three dose levels seroconverted by day 15 after a single dose. At day 43, two weeks following the second dose, at the 25 µg dose level (n=15), levels of binding antibodies were at the levels seen in convalescent sera (blood samples from people who have recovered from COVID-19) tested in the same assay. At day 43, at the 100 µg dose level (n=10), levels of binding antibodies significantly exceeded the levels seen in convalescent sera. Samples are not yet available for remaining participants.”

“At this time, neutralizing antibody data are available only for the first four participants in each of the 25 µg and 100 µg dose level cohorts. Consistent with the binding antibody data, mRNA-1273 vaccination elicited neutralizing antibodies in all eight of these participants, as measured by plaque reduction neutralization (PRNT) assays against live SARS-CoV-2. The levels of neutralizing antibodies at day 43 were at or above levels generally seen in convalescent sera.”

In other words… among the small number of participants (n=12) for which data are available, there was an immune response that may be immunogenic (it works).

So, the DOW stock market index went up 700 points that day because of this news (traders said that’s why it went up at least). Seems like a pretty tenuous reason for such a rally (on an n of 12!).

________________________

UK COVID-19 Vaccine Project Data Shows Efficacy

Six vaccinated macaques and three unvaccinated control macaques were exposed to the virus a month after receiving one dose of the vaccine. The team saw a significantly lower number of viral particles in liquid and fluid taken from the lungs of the animals in the study that had been vaccinated compared with the controls. Here’s more on that “study”

It’s Time for the Governor to Unlock City Government’s COVID-19 Toolbox

The governor’s Stay at Home Order fully expired a couple of weeks ago. So, what have we learned about how Arizonans and Arizona businesses behaved after this 2-week experiment under the new (largely voluntary) expectations? 

You’ve probably made your own observations in the community.  Many retail stores now have decent mitigation measures in place, but not all.  Many customers are paying attention to the social distancing recommendations including distancing and mask wearing in public.  

But, there are also many examples of large groups of people and businesses that are simply ignoring the expectations in Executive Order 36 (provision number 5) which include establishing and implementing best-practice mitigation measures recommended by the CDC and OSHA etc.  Just check out this short video of the goings on in Old Town Scottsdale last weekend.

So why are some places doing it right while some places (and groups of people) are behaving irresponsibly and jeopardizing the health of all of us?  

In a nutshell, I’d say it’s because there’s a lack of enforcement for the scofflaws.  So, what’s the answer?  How can we get the minority of people and businesses that are ignoring mitigation expectations to step it up and start behaving responsibly?

Actually, it’s pretty simple. City governments have the boots on the ground ability to put local ordinances in place and have the resources and the chain of command to make sure that everybody is playing by the rules.

The problem is that Executive Order 36 (provision 7) prohibits city governments from implementing and enforcing mitigation expectations within their jurisdictions.  A simple move that would make a big difference would be for the governor to eliminate the language that ties the hands of city government from doing anything about the scofflaws.

By the way, cities are great at handling local problems. They have extensive experience breaking up nuisance parties and providing local businesses with expectations in line with their zoning requirements.  They also have resources to responsibly get compliance by using city inspectors and even law enforcement if that becomes necessary.  Why not let them do their job- especially now when the stakes are so high?

Arizona is a super diverse state. Just think about the differences between places like Yuma, Chino Valley, Jerome and Old Town Scottsdale. Super different places, both in terms of the spread of COVID-19 and the kinds of behaviors that result in amplifying the virus. The problem is that right now (because of E.O. 36) we have a one-size fits-all statewide policy for a state that isn’t one size.

We urge the governor to tweak Executive Order 36 and give city governments the opportunity to implement and enforce reasonable measures that would allow them to put the brakes on the kinds of behavior in their communities that are jeopardizing the health of the rest of us.

We’ve all sacrificed too much to let our progress slip away because we’ve locked up the toolbox.